Research
Research Funding
Artificial Intelligence-Enabled Electrocardiogram for Cardiovascular Risk Estimation (AIRE) September 2025 - Ongoing
BIDMC & Imperial College London
Principal Investigator: Daniel B. Kramer
This study examines whether artificial intelligence
can use routine electrocardiogram to estimate an individual's risk of mortality and cardiovascular disease. By analyzing subtle electrical patterns that may not be apparent to clinicians, AI-enabled ECG models could improve risk stratification, identify patients who may benefit from earlier intervention, and support more personalized approaches to cardiovascular care. Researchers developed and validated these models using large, diverse patient populations to determine how accurately ECG-derived predictions reflect future health outcomes. The findings may help transform the ECG from a diagnostic tool into a scalable and accessible method for identifying high-risk patients and guiding preventive cardiovascular care
Patch of Asclepius: Technology for Cybersecure Healthcare (PATCH) September 2025 - September 2028
ARPA-H
Principal Investigator: Kevin Fu
The PATCH study aims to improve healthcare cybersecurity
by helping hospitals make safer, faster decisions about when and how to deploy software updates and security patches. PATCH is developing a Vulnerability Mitigation Platform and Whole Hospital Simulation environment that model clinical workflows, operational dependencies, and patient-care impacts to support evidence-based cybersecurity decisions. Focusing particularly on the needs of small and community hospitals, this project seeks to reduce the time between vulnerability discovery and remediation while maintaining safe, uninterrupted patient care.
Remote Alert Pathway To Optimize Care of Cardiac Implantable Electrical Devices: RAPTOR-CIED July 2024 - January 2031
PCORI
Principal Investigator: Daniel B. Kramer
This study explores the effectiveness of alert-driven care
compared to guideline-based care for patients with pacemakers and ICDs. Traditionally, patients follow scheduled in-office and remote transmissions, but routine evaluations often provide little benefit. Alert-driven care, using wireless technology to monitor devices for critical changes, aims to reduce unnecessary appointments and free up clinical resources. This randomized controlled trial will assess outcomes such as major adverse cardiac events and patient-provider experiences, with input from diverse stakeholders, including clinicians, telemedicine experts, and patient advocates.
Study of Response to Injury in Vascular Endothelium: The STRIVE Study February 2024 - February 2025
BIDMC
Principal Investigator: Daniel B. Kramer
The STRIVE Study investigates the vascular response
to injury by analyzing plasma biomarkers during cardiac implantable electrical device (CIED) implantation. This controlled setting allows researchers to measure changes in specific biomarkers before and after the procedure, offering insights into endothelial disruption and its role in thrombosis. The study will collect blood samples to evaluate the feasibility of using CIED procedures as a model for understanding vascular injury. The findings aim to identify biomarkers that could inform future studies and improve patient outcomes related to vascular health.
Prospective Investigation of Palliative and End-of-Life Experiences with ICDs (PIPER-ICD) Study July 2022 - June 2026
NIH; R01
Principal Investigator: Daniel B. Kramer
The PIPER-ICD Study aims to improve care for older
patients living with ICDs by examining their long-term and end-of-life experiences. Around 50,000 ICDs are implanted in patients 65 and older annually, but current guidelines lack robust data on this population. This study will follow patients to assess their clinical and functional trajectories and explore when to replace or deactivate ICDs. With a focus on patient-centered care, the study will also examine ICD shocks at the end of life to identify potential interventions, providing critical data to guide decisions for this group.
The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study April 2021 - March 2026
NIH; R01
Principal Investigator: Daniel B. Kramer
The TRACER-ICD Study aims to enhance shared decision-making
(SDM) for older adults considering ICD implantation. Despite over 50,000 ICDs being implanted annually in patients aged 65 and older, little is known about their long-term health and quality of life. This multi-center study will follow patients and assess their clinical and functional trajectories using data from geriatric conditions and remote monitoring. By refining predictive models of patient outcomes, the study seeks to provide personalized data that can improve SDM and guide better care for millions of older ICD recipients.
Patient-centered Outcomes of Implantable Defibrillator Therapy in Older Patients 2013 - 2017
NIH; K23AG045963
Principal Investigator: Daniel B. Kramer